Home
Conditions
CAR T Cell Therapy

Clinical trial condition

CAR T Cell Therapy

Explore clinical trials studying CAR T Cell Therapy. Study availability and eligibility vary by location and protocol.

10 public trials 4 recruiting studies

Refine in advanced search Browse all conditions

CAR T Cell Therapy trial results

Recruiting

Long-Term Follow-Up of Subjects Treated With Seattle Children's Therapeutics Gene Therapy Products

NCT07424157

Conditions: CAR T Cell, CAR T Cell Therapy
Locations: Seattle Children's Hospital Seattle, Washington, United States

View Trial Details

Recruiting

MB-CART2019.1 in Refractory Multiple Sclerosis

NCT07178431

Conditions: Autoimmune Diseases, Autoimmune Diseases of the Nervous System, CAR T Cell Therapy, +5 more
Locations: Charité Universitätsmedizin Berlin Berlin, Germany

View Trial Details

Recruiting

DALY II Japan/MB-CART2019.1 for DLBCL

NCT07288879

Conditions: CAR T Cell Therapy, DLBCL - Diffuse Large B Cell Lymphoma, Dendritic Cell Sarcoma, Interdigitating, +6 more
Locations: National Cancer Center Hospital Tokyo, Japan

Toranomon Hospital Tokyo, Japan

Juntendo University Hospital Tokyo, Japan

Tokyo Metropolitan Komagome Hospital Tokyo, Japan

View Trial Details

Recruiting

Study of BCMA/CD70 CAR-T Therapy for Refractory cSLE

NCT06934447

Conditions: Autoimmune Diseases, BCMA, CAR T Cell Therapy, +5 more
Locations: hildren's Hospital of Zhejiang University School of Medicine Hangzhou, Zhejiang, China

View Trial Details

Not Yet Recruiting

A Phase II Study to Evaluate the Efficacy of UF-KURE19 Cells in Patients With Relapsed or Refractory B Cell Non-Hodgkin Lymphomas

NCT07713459

Conditions: CAR T Cell Therapy, Diffuse Large B Cell Lymphoma (DLBCL), Follicular B-cell Non-Hodgkin's Lymphoma, +14 more
Locations: Not specified

View Trial Details

Not Yet Recruiting

Functionally Optimized CD33 CAR-T Cell Therapy Targeting Recurrent/Refractory Acute Myeloid Leukemia

NCT07538713

Conditions: CAR T Cell Therapy, CD33 Positive Acute Myelogenous Leukemia
Locations: Not specified

View Trial Details

Not Yet Recruiting

CD19/BAFF-R in Vivo CAR-T Cell Therapy Targeting Relapsed/Refractory B Cell Acute Leukemia/Malignant Lymphoma

NCT07383233

Conditions: Acute Leukemia, CAR T Cell Therapy, Hemic and Lymphatic Diseases, +7 more
Locations: Not specified

View Trial Details

Not Yet Recruiting

Neurological and Cognitive Dysfunction Following CAR-T Treatment. ICANS and Beyond

NCT07375628

Conditions: CAR T Cell Therapy, Cognition Disorders, Cognitive Dysfunction, +7 more
Locations: Not specified

View Trial Details

Not Yet Recruiting

Patient-Reported Outcomes in Allogeneic Stem Cell Transplantation and CAR-T Therapy

NCT07289087

Conditions: Allogeneic Blood and Marrow Transplantation (BMT), Blood Protein Disorders, CAR T Cell Therapy, +19 more
Locations: Not specified

View Trial Details

Completed

Sequential CD19/CD22 CAR-T Cell Therapy Following ASCT

NCT07236151

Conditions: Auto Stem Cell Transplant, CAR T Cell Therapy, Large B-cell Lymphoma
Locations: The First Affiliated Hospital of Soochow University Suzhou, Jiangsu, China

View Trial Details

CAR T Cell Therapy

CAR T Cell Therapy trial results

Related conditions